$LGND filed an 8-K with results (Item 2.02) at 7:14 AM ET on Thu, Oct 29.
LGND
Ligand Pharmaceuticals Inc.−$1.45 (0.45%) Thu · Closed $317.33
−$1.45 (0.46%) ☀ Pre-Market
Oct 30, 8:32 AM ET
About LGND
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Sign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about LGND?
Board · 0 threads
Open board ›Community opinions, not advice. Posts with a target get a receipt. How receipts work ›